ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,411, issued on April 21, was assigned to Aker BioMarine Human Ingredients AS (Lysaker, Norway).
"Phospholipid compositions for delivery of therapeutic compounds" was invented by Thomas Beadnall (Lysaker, Norway), Finn Myhren (Lysaker, Norway) and Nils Hoem (Lysaker, Norway).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions comprising phospholipids for delivery of bioactive compounds such as ethyl esters, fish oil concentrates, cannabinoids, CoQ10 and curcumin under conditions such the bioavailability of the bioactive compounds is enhanced."
The patent was filed on June 5, 2024, under Application No. 18/734...